Clara Maass Medical Center Rated High Performing in Three Adult Procedures and Conditions by US News & World Report


For 2022-2023, Clara Maass Medical Center was recognized by U.S. News & World Report as a high performing hospital in three specialties where it assesses common procedures and conditions in adults: heart failure, kidney failure, and chronic obstructive pulmonary disease (COPD).

A US News & World Report High Performance Rating recognizes care that is significantly better than the national average, based on objective measures such as patient outcomes, including 30-day mortality, 30-day readmission, return home and length of stay.

Mary Ellen Clyne, PhD, President and CEO, Clara Maass Medical Center, said, “It is an honor to be among the hospitals nationwide that have received high performance ratings in three areas and to be able to let to our patients and community that Clara Maass Medical Center will provide the highest level of healthcare when they turn to us. We are constantly striving for excellence and high reliability and these ratings show how well we are able to deliver on that promise.

In 2022-2023, US News & World Report rated hospitals nationwide on a total of 17 common adult procedures and conditions. According to US News & World Report, the goal of providing these assessments is to help patients and their doctors make informed decisions about where to receive care for difficult health conditions or elective procedures.

To arrive at these ratings, US New & World Report evaluated more than 6,000 hospitals nationwide. Some of these hospitals were either too small to be considered or performed too few procedures to be included in the final list.

The hospitals that made the final list fell into three categories: high performing, average or below average, with the majority ranked average. CMMC was one of 1,126 hospitals to receive High Performing for Heart Failure; one of 1,000 hospitals to receive High Performing for Kidney Failure; and one of 1,129 hospitals to receive High Performing for COPD.

About Clara Maass Medical Center

Founded in 1869 as Newark German Hospital, Clara Maass Medical Center, an RWJBarnabas healthcare facility, celebrates over 150 years of service to the community. Conveniently located in Belleville, NJ, Clara Maass Medical Center is a 472-bed hospital that provides a full continuum of care for residents of Northern New Jersey.

Clara Maass Medical Center has completed a state-of-the-art campus expansion of its emergency department, operating rooms and post-anaesthesia care unit with the addition of a four-story medical office building and of 87,000 square feet which includes a private intensive care unit, main entrance and lobby, retail pharmacy and patient registration area. Designated by the New Jersey Department of Health as a Primary Stroke Center, the medical center has achieved national recognition for patient safety and quality from Healthgrades and the Leapfrog Group.

The medical center leads the state in providing advanced ophthalmic treatments and has earned certifications in disease-specific care from the Joint Commission on Acute Coronary Syndrome, Congestive Heart Failure, Elective Heart Replacement hip and knee, cardiac rehabilitation and advanced certification in palliative care and has earned accreditation in bariatric surgery through the Aetna Institute of Quality program. In partnership with the Rutgers Cancer Institute of New Jersey, the only NCI-designated Comprehensive Cancer Center in the state, Clara Maass Medical Center offers an excellent team of researchers and specialists to fight against most types of cancer, offering close access to the latest treatments. and clinical trials. Committed to the health and well-being of its community, the Center of Excellence for Latino Health at Clara Maass Medical Center was created to address the social determinants of health within the local Hispanic community.

The first in the country to be named after a nurse, the hospitals namesake, Clara Louise Maass has been posthumously inducted into the New Jersey Hall of Fame Class of 2017.


Comments are closed.